Rock Springs Capital Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Rock Springs Capital Management’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-850,000	Closed	-$15.1M	–	150
2018 Q3	$15.1M	Buy	850,000 +175,000	+26%	+$3M	0.55%	64
2018 Q2	$9.31M	Hold	675,000	–	–	0.36%	90
2018 Q1	$6.14M	Buy	+675,000	New	+$3.72M	0.26%	107

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Rock Springs Capital Management's ECYT Position: Q4 2018 in Review

Rock Springs Capital Management sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 850,000 shares — an estimated $15.1M sold.

Rock Springs Capital Management first reported a position in ECYT in Q1 2018 and held it in 3 quarters. The position peaked at $15.1M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Rock Springs Capital Management reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Rock Springs Capital Management sold 850,000 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $15.1M.
Rock Springs Capital Management first reported a position in Endocyte, Inc. Common Stock in Q1 2018 and held it in 3 quarters.
Rock Springs Capital Management's Endocyte, Inc. Common Stock position peaked at $15.1M in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Rock Springs Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.